Why can non-selective alpha-blockers cause a fast heart rate?

Blocking presynaptic alpha-2 autoreceptors removes the normal feedback that limits noradrenaline release, so more transmitter reaches cardiac beta-receptors and reflex tachycardia can follow; alpha-1-selective agents largely avoid this.

What does irreversible alpha blockade mean?

Some alpha-antagonists bind the receptor covalently, so the block cannot be overcome by raising catecholamine levels and persists until the cell makes new receptors, unlike competitive blockers whose effect is surmountable.

Alpha-Adrenergic Antagonists

Alpha-adrenergic antagonists, or alpha-blockers, are drugs that occupy alpha-adrenoceptors without activating them, preventing catecholamines from producing alpha-mediated effects. By blocking alpha-1 receptors they relax vascular and other smooth muscle; the class spans non-selective and alpha-1-selective agents, and competitive (reversible) and irreversible blockers.

Troba un tema amb PaperMindAviatFind papers & topics

Tools & resources

Baixa les diapositives

Learn & explore

VídeoAviat

Definition

Alpha-adrenergic antagonists are drugs that bind alpha-adrenoceptors without activating them and block the action of catecholamines, chiefly relaxing smooth muscle through alpha-1 blockade; agents differ in subtype selectivity and in whether their binding is competitive or irreversible.

Scope

This topic covers the alpha-antagonist class — selectivity, reversibility, and mechanism — within autonomic and cardiovascular pharmacology. It is a reference and educational treatment of the drug class and gives no dosing or individualized treatment guidance.

Key concepts

Alpha-1 blockade and smooth-muscle relaxation
Selective versus non-selective alpha-antagonists
Competitive (reversible) versus irreversible blockade
Reflex tachycardia from non-selective blockade
First-dose orthostatic effect
Lower urinary tract smooth-muscle relaxation

Mechanisms

By occupying alpha-1 receptors, these drugs prevent Gq-mediated rises in calcium and relax vascular and other smooth muscle, lowering vascular resistance. Non-selective agents that also block presynaptic alpha-2 autoreceptors remove feedback inhibition of noradrenaline release, which can drive reflex cardiac stimulation; alpha-1-selective agents largely avoid this. Antagonism may be competitive and surmountable or, for agents that bind covalently, effectively irreversible, prolonging the block until new receptors are synthesized.

Clinical relevance

Alpha-1 antagonists are used where smooth-muscle relaxation is desired, including lower urinary tract symptoms of benign prostatic hyperplasia studied in trials such as PREDICT, and have a defined place in cardiovascular pharmacology. The entry explains class mechanism and trial evidence for educational reference and is not a basis for individual prescribing or treatment decisions.

History

Early non-selective alpha-blockers demonstrated the principle of alpha blockade but caused marked reflex tachycardia, traced once presynaptic alpha-2 autoreceptors were recognized. The development of alpha-1-selective antagonists separated useful smooth-muscle relaxation from the reflex cardiac effects of non-selective blockade, and later subtype work refined targeting within the alpha-1 family.

Key figures

Raymond Ahlquist
Solomon Langer
Paul Insel

Seminal works

insel-1996
bylund-1994
kirby-2003

Frequently asked questions

Why can non-selective alpha-blockers cause a fast heart rate?: Blocking presynaptic alpha-2 autoreceptors removes the normal feedback that limits noradrenaline release, so more transmitter reaches cardiac beta-receptors and reflex tachycardia can follow; alpha-1-selective agents largely avoid this.
What does irreversible alpha blockade mean?: Some alpha-antagonists bind the receptor covalently, so the block cannot be overcome by raising catecholamine levels and persists until the cell makes new receptors, unlike competitive blockers whose effect is surmountable.